HomeOwner Search
Visit USCO2013
Category SearchHistone Deacetylase Inhibitors as Cancer Therapeutics-First Edition
Text Registration
Copyright Title
Histone Deacetylase Inhibitors as Cancer Therapeutics-First Edition
Status
Published
on 7 Jan 2013
Year of Creation
2012
Copyright Claimant
Elsevier Inc
Registration Number
TX0007673580
on 7 Jan 2013Copyright Summary
The U.S. Copyright record (Registration Number: TX0007673580) dated 7 Jan 2013, pertains to an electronic file (eService) titled "Histone Deacetylase Inhibitors as Cancer Therapeutics-First Edition" created in 2012. The copyright holder is Elsevier Inc, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Elsevier Inc.
Application Details
Registration Number
TX0007673580
Registration Date
1/7/2013
Year of Creation
2012
Agency Marc Code
DLC-CO
Record Status
New
Physical Description
Book
First Publication Nation
United States
Series Statement
Advances in Cancer Research Volume 116
ISBN
9780123943873
Preexisting Material
permissioned materials
Notes
Rights Note: permissions@elsevier.com
Material Matter Claimed Note: text, compilation, editing
Previous Registration Note: 2012, TX0007581806
Statements
Application Title Statement: Histone Deacetylase Inhibitors as Cancer Therapeutics-First Edition
Author Statement: Steven Grant Domicile: United States Citizenship: United States Authorship: text, compilation, editing
© 2023 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.